Fundraising Fox
Atria Ventures
Venture capitalSan Francisco · Pre-Seed–Seed · 1 people tracked
Also known as Atria
Find your way into Atria Ventures
Each arrow is one introduction. Sign up to fill in the first one.
Ask Dave Bisceglia to introduce you to Chris Leiter
You →Dave · together at Gaingels →Chris
Sign up to find every way you can get introduced to Atria Ventures
- Your email: who you already know at Atria Ventures, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Atria Ventures team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Atria Ventures backs founders working at the edge of computation and biology within the life sciences. Operating as a solo capitalist vehicle, it invests up to $3M at inception and seed, positioning itself as an early and often first believer in technical teams. The firm emphasizes being 'never too early' to engage, supporting companies applying AI and computational approaches to drug discovery, genomics, clinical workflows, biomanufacturing, and biopharma. Its portfolio spans techbio and AI-driven life science startups.
Source: firm website, verified Oct 2, 2026.
Team · 1 people
from public directoriesWhat they invest in
from 15 of 15 portfolio companiesAI & Machine Learning ×13Biotech ×12Healthtech ×5Data & Infrastructure ×4Digital Health ×4Deep Tech ×3Medical Devices ×3Crypto & Web3 ×2
HQs:United States×5
Investments · 15 tracked
founders shown can be your intro path
Abridge builds AI software that converts clinical conversations into structured insights for healthcare providers.
AI & Machine LearningDigital HealthHealthtechPhiladelphia, US
Shiv Rao(Founder & CEO)inSandeep Konam(Cofounder)inJulia Chapin(Executive Officer)Sagar Sanghvi(Executive Officer)in
BoardAndy Weissman(Director)inSebastian Duesterhoeft(Director)in
PartnerChris Leiter· solo GP
Co-investorsAlpha Square Groupalphabet angelsAndreessen HorowitzBessemer Venture PartnersCapitalGCatalio Capital Management, LP+25 more
Axi.om uses agentic intelligence and AI to predict, explain, and fix drug toxicity early in development by leveraging the largest experimental-to-clinical dataset of profiled molecules linked to human clinical outcomes.
AI & Machine LearningBiotechMedical Devices
PartnerChris Leiter· solo GP
Co-investorsAbstract VenturesAmplify PartnersCRV (Charles River Ventures)Inception Studio CapitalDimension Capital
Chai Discovery builds a computer-aided design suite using artificial intelligence to design new molecules and drugs.
AI & Machine LearningBiotechDeep TechSan Francisco, US
Joshua Meier(Founder & CEO)inJack Dent(Founder)in
PartnerChris Leiter· solo GP
Co-investorsAmplify PartnersAvenir Growth CapitalBain Capital VenturesBattery VenturesDCVC (Data Collective)General Catalyst+27 more
.png)
Evolv Life develops orally-delivered biomimetic peptides that activate the body's own GLP-1 and GIP pathways to support appetite control, weight loss, and metabolic health without prescriptions or stimulants.
BiotechDirect to ConsumerWellness & Fitness
Co-investorsAnthropy PartnersFelicis VenturesGeneral CatalystJAZZ Venture PartnersJuniperSeed Capital Bizkaia SA+4 more
.jpeg){kind=logo}
Forus embeds into physician workflows to automate the steps between a clinical decision and a patient starting treatment, including insurance authorization, financial assistance, and fulfillment routing across drugs, payers, and pharmacies.
AI & Machine LearningDigital HealthHealthtechSaaS
Sahir Jaggi(Founder)in
PartnerChris Leiter· solo GP
Co-investorsAccelBain Capital VenturesBoxGroupGeneral CatalystPear VCRedpoint Ventures+1 more
HairDAO is a decentralized research network enabling patients and researchers to collaboratively fund and develop new hair loss treatments through community voting and blockchain-based governance.
BiotechCrypto & Web3Medical Devices
Andrew Verbinnen(Founder)inAndrew Bakst(Founder)in
Co-investorsCompoundMoonlanding Ventures
HoX develops hardware, software, and chemistry capabilities to integrate biological analysis into business and health applications.
AI & Machine LearningBiotechData & InfrastructureDeep TechHealthtechSpokane, US
Phil Hofer(CTO & Cofounder)James van Alstine(CEO & Cofounder)
Co-investorsHAWKTAIL
Molecule operates a blockchain-based platform supporting decentralized science (DeSci), funding research projects and connecting scientists and entrepreneurs.
AI & Machine LearningBiotechCrypto & Web3
Paul Kohlhaas(Founder)in
Co-investorsBackedBoxGroupCompoundFifty YearsIncrypt BlockchainInflection.xyz+13 more
Orchestra is a platform that unifies scientific, operational, and financial data into a single intelligent environment serving biotech and research teams.
AI & Machine LearningBiotechEnterprise Software
Ashoka Rajendra(CEO, Orchestra)inAndy Xu(CTO, Orchestra)in
Co-investors8VCAndreessen HorowitzMoonfire Ventures
Peer AI builds AI-powered tools for drug development and clinical research, with a focus on medical writing and regulatory work.
AI & Machine LearningBiotechDigital HealthSaaS
Anita Modi(Co-Founder & CEO)inChris Ceppi(Co-Founder, CTO & COO)Ravi Ramachandran(Co-Founder & Chief Scientific and Regulatory Officer)in
PartnerChris Leiter· solo GP
Co-investorsAlumni VenturesFlare Capital PartnersGaingelsGreycroftMana VenturesSignalFire
__Twitter.png)
ReSync Bio provided drug discovery teams with no-code access to AI tools for molecular design and analysis, removing the need to build their own infrastructure.
AI & Machine LearningBiotechDeep Tech
MihirNishanthLindsayTonyChelsea
Co-investorsCaffeinated Capital
Sleuth provides evidence-backed answers for biopharma decision-making, built on a knowledge graph that maps over a billion relationships across biology, clinical evidence, competitive dynamics, and deal history.
AI & Machine LearningBiotechData & InfrastructureFintechSan Francisco, US
Andrew Pannu(Executive Officer, Director)
BoardCaleb Appleton(Director)inMark Jacobstein(Director)
PartnerChris Leiter· solo GP
Co-investorsBison VenturesHAWKTAIL
Specie Bio operates BioExchange, an AI-driven platform for finding, matching, and accessing biospecimens and multimodal clinical data from a global network of biobanks, hospitals, clinics, and non-profit institutions.
AI & Machine LearningBiotechData & Infrastructure
Trially uses AI and data science to match patients with clinical trials and accelerate trial recruitment.
AI & Machine LearningDigital HealthHealthtechMedical DevicesKansas City, US
Kyle McAllister(CEO & Founder)inTrevor Welch(Executive Officer, Director)in
BoardThad Langford(Director)in
Co-investorsAlpaca VCCorigin VenturesFlyover CapitalRedbud VCThe CouncilGaingels+2 more
Portfolio news
latest coverage across their companiesForus · citybiz.co · Sep 9, 2026
Chai Discovery · finsmes.com · Jul 14, 2026
Sleuth Insights · intelligence360.news · Nov 3, 2025
Peer AI · prnewswire.com · Oct 7, 2025
Trially · finsmes.com · Sep 17, 2025
Frequently asked questions
- How many investments has Atria Ventures made?
- Atria Ventures has 15 tracked investments, including 3 dated in the last 24 months.
- What stage does Atria Ventures invest at?
- Atria Ventures invests at the Pre-Seed, Seed stages.
- What is Atria Ventures's typical check size?
- Atria Ventures typically writes checks of $500K – $3M.
- What sectors does Atria Ventures focus on?
- Atria Ventures focuses on AI & Machine Learning, Biotech, Deep Tech, Digital Health, Hardware, Healthtech, New Materials.
- Where is Atria Ventures located?
- Atria Ventures is headquartered in San Francisco, US.
- Does Atria Ventures lead rounds?
- Yes, Atria Ventures leads investment rounds.
- Who does Atria Ventures co-invest with?
- Atria Ventures most often shares deals with 8VC, Andreessen Horowitz, Compound, among 57 tracked co-investors.
Images
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Lux Capital is a venture capital firm that backs founders building transformative deep technologies, having been among the first investors in category-defining companies across AI, robotics, biotech, defense, and infrastructure.
AlleyCorp is an early-stage investor and incubator based in New York that builds and backs companies across enterprise, consumer, healthcare, and deep tech sectors.
Snatched Ventures is a San Francisco-based early-stage venture capital firm backing DeepTech startups focused on sustainable innovation and operational transformation. It is led by a two-GP team combining corporate development and institutional investment management experience.
SOSV is a deep tech venture capital firm that makes first-check pre-seed investments and follow-on rounds in startups focused on human and planetary health, providing lab space and hands-on support at its US locations.